New device tested for hardened heart valves
NCT ID NCT04636073
Summary
This early study aimed to test the safety and performance of the Leaflex Performer device in people with severe aortic valve narrowing who had symptoms but were not immediate candidates for valve replacement surgery. The trial planned to follow participants for one year after the procedure to check for complications and measure improvements in walking ability and quality of life. The study was withdrawn before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.